Jiangxi Rimag Group (HKG:2522) intends to buy back up to HK$200 million worth of Hong Kong-listed shares from the open market from time to time, a Monday Hong Kong bourse filing said.
Under its current mandate, the firm can repurchase up to 24.9 million, or 10%, of its issued Hong Kong-listed shares.
Of this, the medical imaging firm has already bought back over 4.4 million shares as of Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments